Chembio Diagnostics - Stock Split History | CEMI

Stock split history for Chembio Diagnostics since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Chembio Diagnostics Annual Stock Splits
Chembio Diagnostics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.097B $0.033B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.122B 20.23
Abbott Laboratories (ABT) United States $141.639B 26.63
Stryker (SYK) United States $79.044B 27.33
Boston Scientific (BSX) United States $52.905B 25.66
Baxter (BAX) United States $44.730B 27.12
EssilorLuxottica Societe Anonyme (ESLOY) France $31.899B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.527B 17.62
Coloplast (CLPBY) Denmark $24.516B 39.14
Lonza Group Ag (LZAGY) Switzerland $24.500B 0.00
Terumo (TRUMY) Japan $23.332B 26.83
Smith & Nephew SNATS (SNN) United Kingdom $20.451B 0.00
ResMed (RMD) United States $18.758B 35.74
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.664B 51.80
Insulet (PODD) United States $9.336B 553.21
Canopy Growth (CGC) Canada $7.103B 0.00
Perrigo (PRGO) Ireland $7.075B 13.03
Hill-Rom Holdings (HRC) United States $6.550B 19.53
Haemonetics (HAE) United States $6.367B 48.05
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.796B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.645B 0.00
Neogen (NEOG) United States $3.284B 54.96
NuVasive (NUVA) United States $3.263B 26.01
ICU Medical (ICUI) United States $3.151B 20.44
Quidel (QDEL) United States $2.356B 23.39
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.303B 0.00
Agios Pharmaceuticals (AGIO) United States $1.869B 0.00
National Vision Holdings (EYE) United States $1.827B 39.44
Cardiovascular Systems (CSII) United States $1.586B 0.00
Aphria (APHA) $1.164B 0.00
VAREX IMAGING (VREX) United States $1.064B 24.53
AtriCure (ATRC) United States $0.978B 0.00
Phibro Animal Health (PAHC) United States $0.849B 13.81
Eagle Pharmaceuticals (EGRX) United States $0.823B 20.97
Omeros (OMER) United States $0.745B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
PetIQ (PETQ) United States $0.722B 17.07
Lantheus Holdings (LNTH) United States $0.721B 18.96
Cerus (CERS) United States $0.623B 0.00
LeMaitre Vascular (LMAT) United States $0.622B 36.89
Surmodics (SRDX) United States $0.569B 108.08
MacroGenics (MGNX) United States $0.553B 0.00
Quanterix (QTRX) United States $0.529B 0.00
TG Therapeutics (TGTX) United States $0.491B 0.00
OraSure Technologies (OSUR) United States $0.461B 21.34
Owens & Minor (OMI) United States $0.410B 12.28
Meridian Bioscience (VIVO) United States $0.377B 11.76
Zynex (ZYXI) United States $0.362B 38.41
Utah Medical Products (UTMD) United States $0.349B 25.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.312B 0.00
BioLife Solutions (BLFS) United States $0.304B 93.44
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.167B 0.00
Rockwell Medical (RMTI) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.137B 0.00
Female Health (VERU) United States $0.134B 0.00
Fonar (FONR) United States $0.127B 8.93
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.084B 19.84
Nephros (NEPH) United States $0.068B 0.00
MTech Acquisition (KERN) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00